ABSTRACT Osteogenesis imperfecta is a clinically and genetically heterogeneous group of inherited connective tissue disorders in which bone fragility is the predominant feature. Cultured dermal fibroblasts from one patient with the lethal perinatal form ofosteogenesis imperfecta secrete type I procollagen at a rate half that of normal cells. Short-term labeling experiments and treatment with a,a'-dipyridyl (which prevents posttranslational prolyl and lysyl hydroxylation) demonstrated that these cells produce two distinct proal(I) chains, which are synthesized at the same rate. Analysis of cyanogen bromide peptides indicated that the two chains differ in their primary structures. Thus, structural abnormalities in type I procollagen prevent this molecule from being secreted normally, resulting in an anomalously low ratio of type I procollagen to other extracellular matrix molecules. While the lethal perinatal form of osteogenesis imperfecta may be heterogeneous, we propose that the underlying pathogenesis of at least one form is decreased secretion of type I procollagen.
Osteogenesis imperfecta (01) is a heterogeneous group of heritable disorders in.which osseous fragility is the common feature (1) . The inheritance pattern, the frequency of bone fractures, and the involvement of tissues other than bone have provided the basis for a recent classification that distinguishes four groups of01 (2) . Additional genetic and biochemical heterogeneity may exist within some or all of these groups (3, 4) . Abnormalities in the metabolism ofcollagen (5-10), glycosaminoglycans (11) (12) (13) , and proteoglycans (14) have all been proposed to account for the clinical findings in 01, but the primary biochemical defect in each form remains unknown.
The most severe form of 01 is type II, also known as the congenital crumpled bone or lethal perinatal variety (2) . Affected infants have major abnormalities in bone formation and extremely friable connective tissue (15) . The distribution of clinical findings corresponds to the distribution of type I collagen in tissues (16) , and decreased production of type I collagen has been observed in cells from a patient with lethal perinatal 01 (6, 17) .
The pathway of collagen biosynthesis is complex, and several alterations could lead to decreased production oftype I collagen (18, 19) . In reexamining cultured cells derived from a well-studied patient (6, 14, 15, 17, 20) with lethal perinatal 01, we have found that the type I procollagen synthesized by these cells is not secreted at a normal rate, and we suggest that failure of secretion is secondary to a structural mutation in one or both proal(I) chains.
MATERIALS AND METHODS
Cell Culture. OI cells (CRL 1262) frozen at subcultivation 9 were obtained from the American Type Culture Collection, Rockville, MD. The cells are derived from the skin ofa stillborn 28-week fetus with the typical features of lethal perinatal OI (15) . Cells were grown in Dulbecco-Vogt modified Eagle's medium that contained 10% newborn calfserum (GIBCO), penicillin at 100 units/ml, and streptomycin at 100 ,ug/ml. Control cells originated from a newborn donor and were frozen at subcultivation 3 (24) , using a rabbit antibody specific for type I procollagen. Antibody specificity was established by sodium dodecyl sulfate/polyacrylamide gel electrophoresis of immunoprecipitates from radiolabeled medium of normal fibroblasts.
Cell layer or medium procollagen was quantitated by scanning densitometry offluorograms (25 . 3 ); the dark band just below proa2 is a partially processed proa2 chain (data not shown). Each lane represents one-half the contents of a single 35-mm dish; the fluorogram was exposed for 4 days. C medium. Furthermore, the bands in the region of proa2 from OI cells and medium (Fig. 2, lanes f and g ) migrated slightly slower than proa2 from control cells and medium (Fig. 2, lanes  e and h) .
In order to identify each band from the OI cultures, we developed a peptide mapping procedure using CNBr digestion of proteins within gels. Strips from a 5% gel (such as the one shown in Fig. 2 , lanes e-h) were cut out while the gel was still wet and were incubated in CNBr. The resulting peptides were separated by electrophoresis in a 12.5% gel as described in Materials and Methods (Fig. 3) . Identical first-dimension strips were processed for fluorography without prior digestion and are illustrated in the upper portion of Fig. 3 . Under these conditions, virtually all of the radioactivity was recovered from the 5% gel. Cleavage with CNBr was incomplete, but it was not increased by prior treatment with reducing agents or by increasing the time and temperature of incubation or the concentration of CNBr used in the cleavage step. The pattern ofpartial cleavage products was highly reproducible.
Peptide maps of the proteins in the OI cells and control medium (Fig. 3A) demonstrated that the two bands that migrated in the region of proal chains from the OI cells were different forms of proal(I) (right side, Fig. 3A ), which we designated proal(I)s and proal(I)f, corresponding to their "slow" and "fast" electrophoretic mobility, respectively. Proal(I)f was distinguished by the presence of a peptide (arrowhead, Fig. 3A ) that was never seen in control proal(I) (medium or cells, see Peptide maps of the proteins in OI medium and control cells (Fig. 3B ) demonstrated that the two bands that migrated in the region of proal chains from the 01 medium represented proal(III) and proal(I). The proal(I)fderived peptide was present in the OI medium (arrowhead, Fig. 3B ) but was much less intense than in the 01 cell layer. This suggested that proal(I), and a small amount of proal(I)f contributed to the band labeled proal(I) in the OI medium (Upper Left, Fig. 3B ). In contrast, the major proal(I) chain in the OI cell layer was proal(I)f (Fig. 3A) . The pattern of CNBr peptides from proa2 was the same in OI and control cultures, so the slight differences in electrophoretic mobility between OI and control whole proa2 chains (Fig. 2, lanes e-h) could not be explained by alterations in primary structure, but it might be due to differences in posttranslational hydroxylation or glycosylation.
Once the bands from the OI cultures were specifically identified, we determined the distribution ofprocollagens between the cells and the medium by scanning gel densitometry ( Table  1 ). The distribution of type I procollagen was markedly altered in the OI cultures; 52% of the type I procollagen in the 01 cultures was retained in the cell layer compared to only 9% in the control. Because virtually all the type III procollagen in the control and OI cultures was in the medium, these results demonstrated a specific abnormality in the secretion of type I procollagen.
The ratio oftype III to type I procollagen produced (cells and medium together) and the ratio oftype III to type I procollagen secreted (medium alone) were also determined by scanning gel densitometry (Table 1) . Type III constituted 11% of the procollagen produced by the OI cultures compared to 7% in controls. Because the OI cells specifically retained type I procol- . Each sample represents the contents of a single 35-mm culture dish; first-dimension fluorograms were exposed for 2 days; the seconddimension fluorograms were exposed for 16 days. lagen, type III constituted 23% of the procollagen secreted by these cells compared to 7% in controls.
To examine the kinetics of procollagen secretion, we pulselabeled the cells and then quantitated the material secreted into the medium by scanning gel densitometry (Fig. 4) . It was not possible to measure type III and type I procollagen separately because not enough radioactivity was incorporated during the pulse (4 hr) for definitive peptide mapping of the proa chains in the OI medium. Therefore, secretion as presented in Fig.  4 includes the contribution of type III procollagen. Nonetheless, the rate of secretion of procollagen by the OI cells was approximately half that of control cells.
The peptide mapping studies suggested that proal(I)f and proal(I)s seen in the OI cells (Fig. 3A , right side) differed in primary structure. To exclude the possibility that they were related as precursor and product, we labeled the cells in the presence of a,a'-dipyridyl, which prevents prolyl and lysyl hydroxylation. Under these conditions the OI cells still pro- pulse-labeling. OI and control cultures were pulse-labeled for 4 hr, the labeling medium was removed, and cell layers were harvested (time 0). Duplicate cultures were then rinsed twice with serum-free growth medium containing ascorbic acid at 5 tkg/ml and 0.1 mM unlabeled proline, and they were subsequently incubated with 1 ml of the same medium. Cell layers and media from replicate cultures were harvested at 30, 60, 120, and 240 min after the initial labeling. The cell layer and medium proteins were separated by electrophoresis, and the collagenous proteins in the medium were quantitated by scanning densitometry. Percent secreted procollagen was measured as: procollagen in medium at indicated time/procollagen in cell layer at time 0. *, Control; *, 01. Short-term continuous labeling shows that the two chains are synthesized at equal rates. Labeling in the presence of a,a'-dipyridyl indicates that the two chains are apparent even in the absence of the usual posttranslational hydroxylation reactions.
Finally, CNBr peptide maps of the separated chains show that proal(I)f produces a strikingly abnormal pattern of CNBr peptides. The pattern of CNBr peptides from proal(I), is also different from normal, but we are uncertain whether this represents an abnormality in primary structure or differential cleavage by CNBr. Although proal(I)f and proal(I), are synthesized at equal rates, after 16 hr, the major proal(I) chain in the 01 medium is proal(I), but the major proal(I) chain in the OI cells is proal(I)f. Because over half of the type I procollagen synthesized by the 01 cells is not secreted, this suggests that type I procollagen molecules that contain one or more proal(I)f chains do not satisfy structural criteria required for secretion.
To date, the major structural requirements for procollagen secretion that have been recognized are presence of an aminoterminal "signal sequence" (26, 27) and triple-helical conformation (28, 29) . If one of the OI proal(I) chains lacked a normal signal sequence or was unable to form a triple helix, the abnormal chain or trimer containing the abnormal chain would be degraded intracellularly (30, 31) . However, the level of intracellular degradation by these OI cells is no greater than that of control cells (17) . This suggests that the abnormal 01 proal(I) chains are assembled and able to form triple helices, but that molecules that contain these chains do not satisfy an additional structural requirement for secretion-e.g., selective interaction with membrane-associated carriers involved in secretion (32, 33) .
This form of OI is genetically heterogeneous (34, 35) ; in some families there is clearly autosomal recessive inheritance, but the occurrence of the disorder in most infants (including the one studied here) is sporadic, so that a new dominant mutation cannot be excluded. Our findings do not distinguish between dominant and recessive inheritance, because it has not been possible to study cells from the parents, and because the number offunctional proal(I) loci is unknown. However, the two 01 proal (I) chains are synthesized at the same rate, suggesting that the genes that code for the two chains are present in the same number ofcopies. This is consistent with a single functional proal(I) locus in bone and skin fibroblasts, so that in these cells one allele is represented by proal(I)f, the other by proal(I)s. If pro al(I)s represents a neutral polymorphism that does not interfere with either function or secretion, then this infant may have had the disorder as a result ofa single mutation that produced proal(I)f.
These 01 cells (CRL 1262) have been studied by several other investigators who described a reduced ratio of type Ito type III collagen production (6), decreased total collagen production, and normal levels of intracellular degradation (17) , increased sulfate uptake (14) , and increased activity of hyaluronate synthetase (20) . Our results demonstrate that the primary genetic defect in these cells is a structural abnormality in type I procollagen that prevents the molecule from being secreted normally and suggests that the other observations are secondary phenomena. The mechanism by which proteoglycan metabolism is altered is unclear, but our results show that the decrease in total collagen production is due largely to decreased type I collagen production. Because collagen degradation was not increased (17) , the reduced ratio of type I to type III collagen produced by these cells (6) must result from a decreased concentration or decreased translational efficiency of type I procollagen mRNA.
We have recently found that cells from four phenotypically similar patients also are unable to secrete type I procollagen normally (unpublished data). Thus, different structural mutations in proa chains that prevent secretion of type I procollagen may underlie the pathogenesis of lethal perinatal 01.
